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Despite  many  recent  advances  in instrumentation,  the  sheer  complexity  of biological  samples  remains
a major  challenge  in large-scale  proteomics  experiments,  reﬂecting  both  the large  number  of  protein
isoforms  and  the wide  dynamic  range  of  their  expression  levels.  However,  while  the  dynamic  range
of  expression  levels  for different  components  of  the  proteome  is  estimated  to be  ∼107–8, the  equivalent
dynamic  range  of LC–MS  is currently  limited  to ∼106. Sample  pre-fractionation  has  therefore  become  rou-
tinely  used  in large-scale  proteomics  to  reduce  sample  complexity  during  MS analysis  and  thus  alleviate
the  problem  of ion  suppression  and undersampling.  There  is currently  a wide  range  of chromatographic
techniques  that  can  be  applied  as  a ﬁrst dimension  separation.  Here,  we  systematically  evaluated  the  use
of  hydrophilic  interaction  liquid  chromatography  (HILIC),  in comparison  with  hSAX,  as  a ﬁrst  dimensionulti-dimensional proteomics
hromatography
ass-spectrometry
for  peptide  fractionation  in  a  bottom-up  proteomics  workﬂow.  The  data  indicate  that in addition  to  its
role  as  a useful  pre-enrichment  method  for PTM  analysis,  HILIC  can provide  a  robust,  orthogonal  and
high-resolution  method  for  increasing  the depth  of  proteome  coverage  in  large-scale  proteomics  exper-
iments.  The  data  also  indicate  that the  choice  of using  either  HILIC,  hSAX,  or other  methods,  is best  made
taking  into  account  the  speciﬁc  types  of  biological  analyses  being  performed.
© 2015  The  Authors.  Published  by  Elsevier  B.V.  This  is  an open  access  article  under  the  CC  BY  license. Introduction
It is not so long since researchers would have counted them-
elves lucky to identify a few tens of proteins from a single shotgun
roteomics experiment. However spectacular progress has been
ade in improving the efﬁciency of protein detection at multiple
evels, including experiment design and protocols, sample prepa-
ation workﬂows, LC–MS instrumentation, and in silico analysis.
s a result, it is now possible to identify a large proportion of a
teady state cell proteome [1] in a single experiment, either with
r without, fractionation [2,3]. Furthermore, it is also possible to
escribe additional proteome dimensions, such as protein turnover
ate, cell cycle-speciﬁc changes, post-translational modiﬁcations
nd subcellular localization [4].
A limitation of early shotgun proteomics experiments is that
he resulting data were predominantly one dimensional: whether
Abbreviations: RP, reverse-phase; HILIC, hydrophilic interaction liquid chro-
atography; hSAX, hydrophilic strong anion exchange; PTM, post-translational
odiﬁcation.
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the sample was derived from either a whole organism, tissue, cul-
tured cells or a puriﬁed organelle or subcellular fraction, the ﬁnal
result was  typically a list of identiﬁed protein groups with limited
quantitative information. However, to describe a cell proteome in
a way that is both accurate and with maximum physiological rele-
vance for understanding biological mechanisms, it is important not
only to include quantitation of protein expression levels, but also
to resolve protein groups into single isoforms (i.e., addressing the
so-called “isoform inference” problem associated with bottom-up
proteomics), while also addressing such parameters as the subcell-
ular distribution of proteins and the presence of post-translational
modiﬁcations (PTMs). This could also be combined with analysis of
additional proteome properties, for example higher order protein
complexes, cell-cycle dependent variations of the proteome, and/or
the rate of protein turnover. This combined analysis approach
has been referred to as either “Next Generation Proteomics” or,
perhaps more accurately, “multidimensional proteomics” [5]. A
major advantage of the multidimensional characterization of cell
proteomes is the ability to mine the resulting data to establish
correlations between different properties, for example linking the
subcellular location of a protein with either a speciﬁc isoform
or post-translational modiﬁcation [6,7]. This can generate useful
hypotheses regarding the functional signiﬁcance of such correla-
tions that can be evaluated directly in follow-on experiments.
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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The comprehensive description of the proteome has to
vercome several analytical challenges, including the inherent
omplexity of protein types in cell extracts and the wide dynamic
ange of protein expression levels. Thus, taking into account iso-
orms and PTMs, a cell proteome can potentially comprise several
undred thousands of protein isotypes, spanning at least ﬁve or
ore orders of magnitude in abundance. As a result, a wide range
f fractionation strategies for peptides and proteins have become
n integral part of proteomics workﬂows, with the general aim of
educing the sample complexity to a manageable level prior to tan-
em mass spectrometry (MS/MS) analysis. This in turn reduces ion
uppression effects and maximizes the number of peptides that are
ffectively transferred to the gas phase as gaseous ions, sequenced
nd successfully identiﬁed.
The most commonly used multidimensional LC setup involves
wo chromatographic separation steps, or dimensions, and is
eferred to as two-dimensional liquid chromatography (2D-LC).
n theory, any type of chromatographic separation can be used
t either the protein, or peptide level, including ion exchange
hromatography (IEC), standard and high pH reversed phase (RP),
ydrophobic interaction chromatography (HIC) and/or size exclu-
ion chromatography (SEC). In bottom up proteomics, however,
D-LC is commonly a combination of an off-line chromatographic
ethod followed by RP-LC directly coupled to the mass spectrom-
ter.
2D-LC has the potential to dramatically improve the separation
ower of chromatography, with its performance depending both on
he peak capacity of the two chromatographic dimensions and their
egree of orthogonality. In chromatography, the term ‘orthogonal’
s used to refer to a complementary method of fractionation from
he initial fractionation, so that orthogonal chromatographic sys-
ems are typically based on the use of different physico-chemical
roperties to separate peptides. In this way, a more effective overall
eparation of the original peptide mixture is provided, ultimately
llowing more peptides to be identiﬁed. A number of studies have
reviously investigated this concept of orthogonality in 2D-LC sep-
ration [8–11]. For instance, it is common to use ion exchange
hromatography prior to RP-LC, as the two techniques are comple-
entary and compatible. In this case the peptides are separated by
harge in one dimension and hydrophobicity in the second dimen-
ion.
In addition to ion exchange chromatography, other approaches
lso offer orthogonality with RP-LC, such as hydrophilic interaction
iquid chromatography (HILIC) [12], which has recently emerged as
 popular chromatographic mode for the separation of hydrophilic
nalytes. HILIC operates on the basis of hydrophilic interactions
etween the analytes and the hydrophilic stationary phase, with
ither highly polar, or hydrophilic compounds interacting most
trongly [13].
There are several different HILIC stationary phases [14,15],
ncluding derivatized silica material, which can be neutral, such
s the cation exchanger polysulfoethyl A [12], the weak cation
xchanger Polycat A [16], the weak anion exchanger PolyWAX [17],
SKgel amide-80 [18,19] and zwitterionic ZIC-HILIC [20,21]. While
hese supports differ in the exact chromatographic mechanism by
hich they separate analytes, they all generate a hydrophilic layer
round the functional groups, which strongly interacts with either
olar, or hydrophilic compounds. Therefore, HILIC can in practice
e viewed as “reversed RP”.
Gradient elution in HILIC can be achieved by increasing the
olarity of the mobile phase, either by reducing the concentration
f organic solvent, or by increasing the salt concentration, depend-
ng on the stationary phase. When peptides are separated using a
on-ionic stationary phase, such as TSKgel Amide-80, an inverse
cetonitrile gradient is most convenient. If the separation is carried
ut using ionic packing, such as that contained in PolyHydroxyethylass Spectrometry 391 (2015) 105–114
A columns, an increasing salt gradient is normally used. When using
the TSKgel Amide-80 stationary phase, it is necessary to include a
pairing agent, such as TFA, in the mobile phase to prevent ionic
interactions between peptide residues and residual silanol groups
on the silica surface. The use of weaker acids was reported to neg-
atively affect the chromatography by reducing peptide elution and
broadening peaks [22]. In the absence of acid, the separation is
based on mixed mode (polar interactions and ionic interactions)
[22]. TFA results in ion suppression when the eluent is directly
sprayed at the sampling region of the mass spectrometer, how-
ever it is not an issue at all to use in off-line preparative LC, as is
the case of a 2D-LC set up. One of the major issues affecting the
ability to combine HILIC and RPLC in an online setup has been the
incompatibility of the solvents used in both dimensions. However,
recently Di palma et al., reported a robust 2D-LC setup allowing the
combination of the separation modes [23].
A number of previous studies have compared the performance of
HILIC against other chromatographic separation modes, including
strong cation exchange (SCX) and reversed phase (RP). SCX is com-
monly used for peptide fractionation in 2D-LC setups. However, SCX
suffers from low resolution as well as the additional requirement
for desalting, which may  result in losses, especially in phospho-
rylated peptides and hydrophilic peptides in general. Studies that
have compared ZIC-HILIC and SCX side by side have reported that
the former has higher resolution and results in increased num-
bers of identiﬁcations [20,24]. HILIC also performed better on
iTRAQ-labelled samples [24,25] and was  reported to reduce iTRAQ
ratio-compression, a fact which has been attributed to its higher
resolution [26].
The efﬁcacy of HILIC for the separation of polar compounds
has been effectively exploited in the study of PTMs, including car-
bohydrates [27,28], glycopeptides [29–31] and phosphopeptides
[18,32].
HILIC has also been used in combination with selective phos-
phopeptide enrichment methods, such as either immobilized metal
afﬁnity chromatography (IMAC) [33,34], or TiO2 [35] enrichment
in different orders. Phospho-enrichment ﬁrst: For example, Albu-
querque et al. [36] reported the development of a multidimensional
chromatography method combining IMAC, HILIC and RP-LC to
purify and fractionate phosphopeptides. They showed that HILIC
was largely orthogonal to RP-HPLC for phosphopeptide enrich-
ment. Wu et al. [37] combined dimethyl labelling, IMAC separation
and HILIC fractionation to identify 2857 unique phosphorylation
sites in the MCF7 breast cancer cell line. HILIC ﬁrst: Annan and
Mcnulty reported the use of HILIC as a pre-enrichment step prior to
IMAC-based phospho-enrichment for large scale proteomics stud-
ies [18]. This approach was successfully adopted in other studies
[38,39].
HILIC has also been employed either before, or after, phospho-
enrichment. Thus, Engholm-Keller et al. reported a combination
of a large-scale phosphoproteomics protocol prior to HILIC frac-
tionation and TiO2 enrichment [40]. By using sequential elution
from IMAC (SIMAC) [41], mono-phosphorylated peptides are sep-
arated from multiphosphorylated peptides. Non-phosphorylated
and monophosphorylated peptides were further fractionated using
HILIC, followed by TiO2 chromatography of the HILIC fractions. This
demonstrated the feasibility of performing large-scale quantitative
phosphoproteomics on submilligram amounts of protein that could
be applied to cell material of low abundance.
Although, early studies on peptide separation by HILIC mainly
focused on its resolution power and orthogonality as a ﬁrst fraction-
ation method in a multidimensional set up, there have also been
reports evaluating its signal intensities and its applicability in an
online HILIC-ES-MS as an alternative to RP-ES-LC. The high organic
content used in HILIC results in a peptide signal increase by a factor
of 2–10 fold in 88% of cases investigated (81 peptides), compared
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ith RPLC, thus improving the sensitivity of both peptide detection
nd quantiﬁcation [42]. Maximum sensitivity was obtained when
sing amide columns without any salt additives. Yang et al. [43]
eanwhile have evaluated the different stationary phases used in
ILIC, addressing the effect of mobile phase composition on peak
fﬁciencies with an online HILIC-ES-MS system using peptide mix-
ures and protein digests. This showed that the use of HILIC-ES-MS
rovided complementary separation selectivity to RPLC-ES-MS and
ffered the capability to identify unique peptides, thus highlighting
ts potential in proteomic applications.
In addition, Horie et al. described the use of a meter-scale mono-
ithic silica capillary column modiﬁed with urea functional groups
or use in the HILIC mode, which provided highly orthogonal sep-
ration to RPLC with sufﬁcient peak capacity, as well as highly
ensitive detection for tryptic peptides. In effect, they reported on
verage ∼5-fold increase in the peak response for commonly iden-
iﬁed tryptic peptides due to the high acetonitrile concentration
n the HILIC mobile phase suggesting its application as a comple-
entary tool to increase proteome coverage in proteomics studies
44].
In this study, we extend the characterization of HILIC to evaluate
ts applications in proteomics workﬂows beyond the enrichment of
ydrophilic analytes. Speciﬁcally, we systematically evaluate the
erformance of HILIC against the popular, hydrophilic strong anion
xchange (hSAX) method of peptide fractionation, which separates
eptides based on their charge [45].
. Materials and methods
.1. Cell culture
U2OS osteosarcoma cancer cells were obtained from the Euro-
ean Collection of Cell Cultures and grown in Dulbecco’s Modiﬁed
agle Medium (Lonza) supplemented with 10% fetal bovine serum
Gibco), 50 units/mL penicillin (Lonza) and 50 g/mL streptomycin
Lonza) for no more than 30 passages at 37 ◦C and 5% CO2.
.2. Protein extraction and proteolytic digestion in solution
For protein extraction, cells were washed twice with cold PBS
nd then lysed in 0.3–1.0 mL  urea lysis buffer (8 M urea, 100 mM
riethyl ammonium bicarbonate (TEAB) pH 8.5, Roche protease
nhibitors, Roche PhosStop). Lysates were sonicated on ice (6 cycles,
0% power, 30 s). Proteins were reduced with TCEP (25 mM),  for
5 min  at room temperature and alkylated with iodoacetamide
50 mM),  in the dark for 45 min  at room temperature. Lysates were
iluted with digest buffer (100 mM TEAB) to a ﬁnal concentration
f 4 M urea and digested overnight at 37 ◦C with endoprotease Lys-
 (Wako Chemicals, Japan) using an enzyme to substrate ratio of
:50. The digest was diluted further using 100 mM TEAB to a ﬁnal
oncentration of 0.8 M urea and subjected to a second digestion
sing trypsin (Promega) in a 1:50 ratio. Finally, the digestion was
uenched by adding triﬂuoroacetic acid (TFA) to a ﬁnal concentra-
ion of 1% (v:v).
.3. Peptide desalting and solid phase extraction
Prior to fractionation, the peptide samples were desalted using
18 Sep-Pak cartridges (Waters). Cartridges were ﬁrst activated
ith Acetonitrile (ACN) and equilibrated with 50% ACN in water
ccording to the manufacturer’s protocol. The sample was loaded
nd washed 4 times with 500 L water containing 0.1% TFA. The
eptides were eluted into a fresh Eppendorf tube with 800 L 50%
CN containing. The peptides are then dried in vacuo.ass Spectrometry 391 (2015) 105–114 107
2.4. Off-line HILIC fractionation
HILIC was performed on a Dionex UltiMate 3000 (Thermo Sci-
entiﬁc) using a similar protocol to the method described previously
[6,18,46].
The dried peptides were redissolved in 80% ACN incorporating
0.1% TFA. The peptides were resolved on TSK-gel amide 80-column
(TOSOH) using an inverted organic gradient of solvent A (water,
0.1% TFA) and solvent B (ACN, 0.1% TFA). The fractions were col-
lected in deep well 96 well plate. They were dried and redissolved
in 5% formic acid (FA).
2.5. Off-line hSAX
hSAX was  performed on a Dionex UltiMate 3000 (Thermo Sci-
entiﬁc) using a similar protocol to the hSAX method described
previously[6,46].
Brieﬂy, tryptic peptides were desalted using Sep-Pak-C18 SPE
cartridges (Waters), dried, and dissolved in 50 mM borate, pH 9.3.
They were then loaded on AS24 strong anion exchange column and
fractionated using an exponential elution gradient from 100% sol-
vent A (10 mM sodium borate, pH 9.3) to 100% solvent B (10 mM
sodium borate, pH 9.3 + 0.5 M sodium chloride) using a ﬂow rate of
250 L min−1.
Fractions were collected into a 96-well plate from 5 to 55 min
to give 16 fractions. They were acidiﬁed and desalted using Sep-
Pak-C18 solid-phase extraction (SPE) plates (Waters). The plates
were ﬁrst wetted with 50% acetonitrile (ACN) in water, washed
and equilibrated with water containing 0.1% TFA. The acidiﬁed pep-
tide fractions were loaded onto the plates, washed with water
containing 0.1% FA and then eluted with 300 L 50% aqueous
ACN containing 0.1% TFA. The desalted hSAX fractions were dried
in vacuo and redissolved in 5% FA prior to RP-LC–MS.
The elution programme was  100% buffer A for 10 min, contin-
ued by a short (1 min) gradient of 0–3% of buffer B, followed by a
gradient of 3–15% for 19 min, a 15–45% gradient for 15 min and a
45–100% gradient for 2 min. At the end of the gradient the column
was kept at 100% buffer B for 7 min  and then for 10 min  in buffer A.
2.6. Online RP-LC–MS analysis
The peptide samples were dissolved in 5% FA. Their concentra-
tion was determined using CBQCA assay (Life Technologies).
RP-LC was performed using a Dionex RSLC nano HPLC
(Thermo Scientiﬁc). Peptides (1 g) were injected onto a 0.3 mm
id × 5 mm PepMap-C18 pre-column and chromatographed on a
75 m × 15 cm PepMap-C18. Using the following mobile phases:
2% ACN incorporating 0.1% FA (solvent A) and 80% ACN incorpo-
rating 0.1% FA (solvent B), peptides were resolved using a linear
gradient from 5% B to 35% B over 156 min  with a constant ﬂow of
200 nL min−1. The peptide eluent ﬂowed into a nano-electrospray
emitter at the sampling region of a Q-Exactive Orbitrap mass
spectrometer (Thermo Scientiﬁc). The electrospray process was ini-
tiated by applying a 2.5 kV to liquid junction of the emitter and
the data were acquired under the control of Xcalibur (Thermo Sci-
entiﬁc) in data dependent mode. The MS  survey scan (MS1) was
performed using a resolution of 60,000. The dependent HCD-MS2
events were performed at a resolution of 17,500. Precursor ion
charge state screening was enabled allowing the rejection of singly
charged ions as well as ions with all unassigned charge states.
2.7. Data analysisThe raw MS  data from the Q-Exactive Orbitrap (Thermo Scien-
tiﬁc) were processed with the MaxQuant software package (version
1.3.0.5). Proteins and peptides were identiﬁed against the UniProt
1 al of Mass Spectrometry 391 (2015) 105–114
r
s
m
m
C
O
a
t
f
A
p
s
3
t
a
a
3
L
b
f
t
m
v
t
f
o
w
H
l
p
m
w
a
a
a
5
o
h
d
u
r
3
a
p
t
i
i
c
t
T
p
3
R
H
Fig. 1. Schematic representation of the proteomics workﬂow. Protein samples were
puriﬁed from cultured human cells, or nematodes, and digested with trypsin and08 D. Bensaddek et al. / International Journ
eference proteome database (August 2013) using the Andromeda
earch engine [47,48]. The following search parameters were used:
ass deviation of 6 ppm on the precursor and 0.5 Da on the frag-
ent ions; Tryp/P for enzyme speciﬁcity; two missed cleavages.
arbamidomethylation on cysteine was set as a ﬁxed modiﬁcation.
xidation on methionine; phosphorylation on serine, threonine,
nd tyrosine; hydroxylation on proline and acetylation at the pro-
ein N-terminus were set as variable modiﬁcations. Thresholds
or the identiﬁcation of phosphopeptides were Delta Score = 6 and
ndromeda score = 40. The false discovery rate was  set to 5% for
ositive identiﬁcation of proteins, peptides, and phosphorylation
ites.
Most of the subsequent data analysis was done in R version
.1.3 [49] using Rstudio 0.98.1091 and the package ggplot2 [50];
he sequence coverage analysis was done using Perseus 1.5.1.6 [47]
nd the GO-terms enrichment analysis using the Cytoscape [51,52]
pp BiNGO.
. Results and discussion
In this study we compared two 2D-LC setups, i.e., HILIC–RP-
C/MS and hSAX–RP-LC/MS, using unfractionated cell lysates from
oth cultured mammalian cells and from nematodes (Fig. 1). To
acilitate a meaningful comparison of these two  approaches, we
ook into consideration the differences in scale and practical imple-
entation of both techniques, including sensitivity levels, system
olumes/ﬂow rates and fraction collection. We  note, for example,
hat it is not possible to use the same amount of starting material
or each method without either diluting the sample, or overloading
ne or other of the systems.
Peptide fractionation using hSAX provides good separation
hen loading relatively low (e.g. ∼100 g) amounts of material.
owever, this in our experience is below the maximum practical
oading capacity of hSAX, allowing us to increase the amount of
eptides injected to limit sample dilution. In contrast, HILIC has a
aximum loading capacity for peptides in the order of milligrams,
hile a minimum of ∼500 g is required to achieve reasonable sep-
ration. Given this intrinsic difference in loading capacities for hSAX
nd HILIC, in the following experiments to allow us to load equal
mounts of material on both set-ups, we chose a concentration of
00 g that was near the lower limit for HILIC separation to avoid
verloading the capacity of the hSAX system.
To ensure robustness and stability of the RP-LC–MS analysis we
ave also injected 1 g of each fraction on the RP-C18 column,
etermined using a ﬂuorescent assay (see Section 2 for details) and
sed the same standard RP-LC–MS method in each case (summa-
ized in Fig. 1).
.1. Comparing resolution of HILIC and hSAX
To assess the resolution of chromatographic separation by HILIC
nd hSAX we have taken the approach of measuring the number of
eptides that are only identiﬁed in a single fraction and measuring
he degree of overlap between adjacent fractions. Higher resolution
s obtained when a given peptide is only present in one fraction (or
n small number of fractions). Thus, for both HILIC and hSAX we
ompared the number of peptides identiﬁed in a single fraction,
wo fractions and so on and the results are summarized in Fig. 2.
his shows a slightly superior resolution for HILIC where >70% of
eptides were observed in a single fraction.
.2. Comparing orthogonal behaviour of HILIC and hSAX with
P-LC
Next, we compared to what extent the separation properties of
ILIC and hSAX were orthogonal with RP-LC (Fig. 3). Both methodsLys-C into individual peptides. To reduce sample complexity, peptides were sub-
jected to “off line” sub-fractionation, either HILIC or hSAX, prior to analysis by
LC–MS.
show good orthogonality with RP-LC as can be seen from the dis-
tribution of peptide intensities across the RP-LC chromatogram for
HILIC fractionated peptides (Fig. 3A) and hSAX fractionated pep-
tides (Fig. 3B). From this ﬁgure, we can see that there is a broad
distribution of ions across the retention time resulting in a wide
separation of peptides across the 2D-space.
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In addition, we note that while both methods offer good orthog-
nality they are not identical. This suggests that each technique
ay  have intrinsic speciﬁcities that would be relevant to their use
n proteomics workﬂows.
.3. Exploring the consequences of orthogonality
.3.1. Depth of proteome coverage
Not surprisingly, incorporating either the HILIC, or hSAX meth-
ds into the MS  workﬂow allowed a substantial increase in the
epth of the proteome measured, in comparison with using RP-LC
lone. However, as expected, based on the different physico-
hemical properties used to fractionate the peptides, HILIC and
SAX favour different subsets of peptides and proteins. For exam-
le, when analyzing extracts of U2OS cells, both set-ups allowed
he identiﬁcation of >9,500 proteins, with hSAX identifying 9,935
ig. 3. Comparison of the orthogonality of HILIC-RP and hSAX-RP. The ﬁgure shows a hea
rom  a (A) HILIC and (B) hSAX method, across retention time.ass Spectrometry 391 (2015) 105–114 109
proteins and HILIC identifying 9,612 proteins, (Fig. 4A). We  note
that even though here hSAX identiﬁes slightly (∼3%) more pro-
teins, there is still a subset of speciﬁc proteins (∼500) that are only
identiﬁed in the HILIC–RP-LC experiment. Interestingly, this HILIC-
speciﬁc group mainly corresponds to proteins that are identiﬁed
by post-translationally modiﬁed peptides (also referred to as site
modiﬁcations). As discussed further below, this highlights a speciﬁc
advantage of using HILIC when the identiﬁcation of PTM-modiﬁed
proteins is highly relevant to the biological experiment involved.
When looking at the total number of peptides identiﬁed, as
opposed to proteins, hSAX outperforms HILIC, here identifying
more total peptides (Fig. 4B). However, even though hSAX iden-
tiﬁed substantially more peptides than HILIC, there is still a subset
of peptides that were exclusively identiﬁed by HILIC, correspond-
ing predominantly to hydrophilic and/or heavily modiﬁed peptides.
Despite the higher overall number of peptides identiﬁed in the
hSAX–RP-LC setup, it is signiﬁcant that this does not result in a
dramatic increase in the average protein sequence coverage from
that measured by HILIC-RP. Instead we observe that the two 2D-LC
techniques are on par with each other, with ∼27% average sequence
coverage for proteins identiﬁed by either hSAX–RP-LC, or HILIC–RP-
LC (Fig. 4C).
It should be noted that in this study we have speciﬁcally
analyzed peptides resulting from the double digestion of the pro-
teome with trypsin + Lys-C, i.e., essentially tryptic peptides. These
peptides have the advantage of possessing a basic residue at
their C-terminus, which facilitates ionization under the conditions
of online RP-LC and aids efﬁcient fragmentation using collision
induced dissociation (CID). However, amongst the set of tryptic
peptides generated, a signiﬁcant proportion (∼56%) are too short
(<6 amino acid residues) to be identiﬁed reliably by LC–MS/MS
based methods [53].
One approach to increase the average protein sequence cover-
age further could be to employ parallel digestions using several
proteases with different cleavage speciﬁcities, subsequently com-
bining the results. This approach was  reported recently to result
in a signiﬁcant increase in sequence coverage, which is furtherdem MS  experiment [53,54]. The multiple protease approach will
result in peptides that are heterogeneous with regards to the posi-
tion of basic residues and will not therefore be ideal for CID. For
tmap of total ion current (TIC), scaled to respective highest value, for each fraction
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Fig. 4. Comparison of the performance of HILIC and hSAX. Euler diagrams of (A)
proteins and (B) peptides identiﬁed in HILIC (red) and hSAX (blue) datasets. (C)
Sequence coverage of proteins identiﬁed using HILIC and hSAX. (D) Molecular func-
tion GO-terms enriched in the hSAX dataset. No speciﬁc GO term was  found to be
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tnriched in proteins exclusive to the HILIC dataset. (For interpretation of the refer-
nces to colour in this ﬁgure legend, the reader is referred to the web  version of the
rticle.)
xample, peptides that contain internal basic residues will give
ise to internal fragments that are usually unassigned by current
atabase search algorithms and their identiﬁcation would bene-
t from using alternative activation techniques, such as electron
ransfer dissociation (ETD) and more recently ultraviolet photodis-
ociation (UVPD).
.3.2. Gene ontology analysis
As demonstrated above, in addition to a major overlap, hSAXnd HILIC favour detection of different subsets of peptides and
roteins. To investigate the natures of the differences in protein
dentiﬁcations, we employed Gene Ontology analysis. To do this,
he protein lists were submitted for statistical testing to identifyass Spectrometry 391 (2015) 105–114
the functional categories of enriched genes deﬁned by Gene Ontol-
ogy (GO) using the BiNGO app from Cytoscape [51,52] as well as
using DAVID (http://david.abcc.ncifcrf.gov/home.jsp) [52,55]. The
results reveal that hSAX clearly enriches for speciﬁc classes of pro-
tein sequence features, especially different types of the zinc ﬁnger
regions C2H2. Amongst the GO-molecular function terms enriched
are ion binding, DNA binding and metal binding. Fig. 4D shows the
Cytoscape GO term networks, highlighting biological processes that
are signiﬁcantly enriched in the hSAX protein list. The full results
of the GO analysis are shown in Supplementary Table 1.
Supplementary table related to this article can be found, in the
online version, at http://dx.doi.org/10.1016/j.ijms.2015.07.029.
Interestingly, a GO term analysis on a similar number of proteins
speciﬁcally detected in the HILIC fraction showed no signiﬁcant
enrichment of either sequence motifs, or any GO terms associated
with function (data not shown). This is consistent with the fact
that HILIC uses polarity/hydrophilicity to fractionate peptides, a
property that shows little or no speciﬁcity for functional classes
of proteins. In contrast, hSAX will preferentially enrich classes of
proteins that contain highly charged regions, such as nucleic acid
binding proteins. We  infer that HILIC displays minimal bias relat-
ing to GO-terms beyond any intrinsic sampling bias inherent to the
extract preparation methods.
3.4. Is HILIC undersampling?
Next, we investigated possible reasons that could explain the
lower numbers of peptides identiﬁed by HILIC-RP. We started by
examining the number of successful peptide identiﬁcations per
fraction for each of the 2D-LC set-ups (Fig. 5). This shows a dra-
matic decrease in the number of peptides identiﬁed in the later
fractions of HILIC (Fig. 5A). In fact, there is a gradual decrease in the
number of peptides identiﬁed from fraction 9 to fraction 16, with
successful peptide identiﬁcations made early in the RP-LC gradient
in keeping with the increased hydrophilic character of these pep-
tides. In contrast, the number of peptide identiﬁcations is uniformly
distributed across the hSAX fractions and across the RP-LC chro-
matogram (Fig. 5B), suggesting that most/all of the hSAX fractions
are similar in terms of their hydrophobicity.
Analysis of the percentage of successful MS2  identiﬁcations
across fractions in each experiment shows a dramatic decrease in
the number of successful MS2  identiﬁcation in HILIC, as compared
with hSAX fractionation (Fig. 5C). A possible explanation is that the
later HILIC fractions are largely empty, with very few peptides that
can be selected for MS/MS. However, this is not the case, as shown
by looking at the numbers of tandem MS  spectra acquired across
all of the HILIC fractions, which are similar to the number of spec-
tra acquired for hSAX fractions (Fig. 5D). This shows that the total
number of MS/MS  spectra acquired is relatively constant across the
HILIC fractions.
When, for each HILIC and hSAX fraction, the total intensities
from the raw chromatogram (total ion current, cf. Fig. 3) and from
the successfully sequenced spectra are plotted side by side (Fig. 5E
and F for HILIC and hSAX, respectively), it becomes apparent that
while the later HILIC fractions do appear to be lower complex-
ity than the earlier ones, they are also yielding relatively fewer
sequenced evidences. We  conclude therefore that it is the percent-
age of spectra that led to successful peptide identiﬁcations that has
dropped in the later fractions of HILIC.
Several factors may  be contributing to the observed decrease
in successful peptide assignments from the spectra recorded
from the later HILIC fractions. First, these later fractions may
be preferentially enriched in peptides containing one or more
post translational modiﬁcations that we have not included in our
database searches and as a result we  were blind to these peptides.
For example, HILIC has been reported to successfully enrich for
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Fig. 5. Comparison of the efﬁciency of the conversion of MS/MS spectra into peptide identiﬁcations between HILIC and hSAX. Representation of the sequenced evidences
proﬁle of each of the (A) HILIC and (B) SAX fractions across runtime. This plot represents, for each fraction, the retention length of all identiﬁed peptide evidences, represented
as  a segment centred on their retention time, where each segment’s colour intensity is a function of evidence intensity. Segment positions are dodged on either side of the
horizontal axis to avoid overlap, with the least intense ones towards the periphery; hence, the width of the segment cloud is a function of the number of peptides eluting at
the  time point considered. (C) Percentage of MS/MS  spectra which resulted in a successful identiﬁcation, i.e., in a peptide-spectrum match (PSM), per fraction. (D) Number
of  MS/MS  spectra acquired per HILIC and hSAX fraction. (E and F) Scaled relative intensity proﬁle for total ion current (TIC, dashed line) and successfully identiﬁed spectra
(“evidences”, full line, mirrored) for HILIC and hSAX, respectively. (G) Mean peptide charge per HILIC and hSAX fraction.
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Fig. 6. Distribution of examples of hydrophilic PTMs across HILIC and hSAX frac-
tions. Mean number of (A) phosphorylations and (B) hydroxy-proline modiﬁcations
detected per number of peptides across fractions for HILIC and hSAX. (C) Number of
phosphorylations per peptide for three biological replicates fractionated using the
same HILIC method.12 D. Bensaddek et al. / International Journ
-GlcNAc containing peptides and sialic acid containing glycopep-
ides [56], amongst other sugars, which were not used as variable
odiﬁcations when interrogating the database in this study [57].
imilarly, these peptides may  carry other known modiﬁcations that
ere not searched for and/or rare, or even novel, modiﬁcations,
hich may  be unknown to us. Therefore, these peptides could be
deal targets for future analysis by de novo sequencing, rather than
eeking to identify them by database matching.
Second, there may  be a decline in the quality of the spectra in
he later HILIC fractions, reducing the number of spectra that are
ood enough for successful peptide identiﬁcation. Successful pep-
ide identiﬁcation can be achieved only when product ions from
 complete or nearly complete distribution of amide backbone
leavages are observed in the corresponding MS/MS  spectrum. This
ould arise if these fractions are enriched in peptides that are mod-
ﬁed in a way that alters either their behaviour, or fragmentation
attern, when subjected to HCD (and more generally CID).
Brieﬂy, in this process, peptides that are protonated more or less
andomly on backbone amide nitrogen atoms [58] are collided with
n inert gas. Imparted kinetic energy is converted to vibrational
nergy, which is then rapidly distributed throughout all covalent
onds in the peptide (picosecond time scale). Fragment ions are
ormed when the internal energy of the ion exceeds the activation
arrier required for a particular bond cleavage. Fragmentation of
rotonated amide bonds affords a series of complementary product
ons of types b and y [59–61], which allow assignment of a peptide
equence to a precursor ion.
In this case the peptides in later HILIC fractions may  not pro-
uce ideal fragmentation under the CID regime and hence not
ield assignable MS2  spectra. For example, they may  be heavily
odiﬁed, by carrying several phosphate groups, or other labile
roups, that readily dissociate by a lower energy pathway than that
nvolved in the cleavage of the amide linkage, thus reducing the
xtent of backbone cleavages and so making the spectra difﬁcult
o assign. For example, in the gas phase, the phosphate competes
ith the peptide backbone as a preferred site of protonation and
onsequently, after collisional activation, undergoes nucleophilic
isplacement by a neighboring amide carbonyl group. The result-
ng [(M+nH)n+−H3PO4] product ions often constitute ≥85% of the
ragment ions observed under the low-energy CID conditions.
Identiﬁcation of such peptides could beneﬁt from using alter-
ative activation methods, such as electron transfer dissociation
ETD) [62], which results in backbone cleavage even in the presence
f labile PTMs. This is due to the fact that ETD, like its predecessor
CD, is independent of amide bond protonation and occurs on a
horter time scale compared with internal energy distribution so
hat heavily modiﬁed peptides fragment more or less randomly
long the peptide backbone and are easily sequenced.
It is also possible that the unassigned peptides are highly
harged, so that when subjected to CID they give rise to MS2
pectra that are too complicated for reliable database searching
nd identiﬁcation. The presence of multiple basic residues in the
equence inhibits random protonation along the peptide backbone
nd thus reduces the extent of backbone cleavage, which is com-
only accepted to occur predominantly through charge-directed
athways (the mobile proton model) [63].
Again, exploring other activation methods could be beneﬁ-
ial. For example, Coon and co-workers have reported that highly
harged species gave more useful sequence information under
TD while lower charged species (2+ and 3+ charge states) gave
ore successful assignments under the CID regime leading to the
ntroduction of decision tree based proteomics to improve the
equence coverage of the proteome [64]. We  note that in Fig. 5E,
he hSAX fractions have a relatively constant distribution of charge
tates (2+ and 3+) which are consistent with them showing more
onstant MS2  assignments throughout the fractions in contrast
al of M
w
t
o
w
r
f
t
h
h
c
e
t
d
4
a
i
e
a
i
p
t
a
c
c
R
a
t
r
w
b
t
o
t
c
o
c
f
ﬁ
o
h
s
h
t
t
t
u
t
p
P
e
p
h
o
A
o
t
t
d
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[
[D. Bensaddek et al. / International Journ
ith the unequal distribution of ion charges across the HILIC frac-
ions.
Consistent with the possibilities discussed above, we indeed
bserve more phosphorylated peptides in the later HILIC fractions,
here we have increased the polarity of the mobile phase and
educed its organic content (cf. Fig. 6). Analysis of extracts prepared
rom both human cell lines and nematodes shows a consistent
rend, with ∼30% of the peptides in the latter fractions having
ydrophilic modiﬁcations, such as phosphorylation and/or proline
ydroxylation (Fig. 6).
In summary, we observe a gradient of peptide identiﬁcation efﬁ-
iency across the HILIC fractions that may  reﬂect the preferential
nrichment in the later fractions of classes of hydrophilic peptides
hat are currently difﬁcult to identify efﬁciently using conventional
atabase search algorithms.
. Conclusion
Given the diversity of physico-chemical properties of proteins
nd their post-translationally modiﬁed forms, it is likely that there
s no ‘one size ﬁts all’ fractionation method that will allow perfectly
fﬁcient detection and measurement of all proteins and peptides in
 single experimental setup. If the goal of a given proteomic study
s to obtain the most comprehensive measurement of all forms of
roteins in a cell, tissue or organism, then it is likely that more
han one analytical technique will be required to maximize cover-
ge. There are available now multiple chromatography setups that
an be linked with tandem MS  analyses and in this study we  have
ompared speciﬁcally the performance of combining conventional
P-LC–MS with either HILIC, or hSAX, respectively. Both methods
llowed an increase in the depth of proteome coverage as opposed
o using RP-LC alone. In addition, the data show that both methods
esulted in approximately equal numbers of protein identiﬁcations
ith similar average sequence coverage; despite the higher num-
er of total peptide identiﬁcations obtained using hSAX as opposed
o HILIC.
Overall the data in this study show that hSAX is highly
rthogonal with RP-LC and can be easily applied in large-scale pro-
eomics, providing deep proteome analysis with good sequence
overage. The data also show that hSAX has slightly lower res-
lution than HILIC, in keeping with recent reports by Trost and
o-workers [45], who have shown ∼55% of peptides eluting in one
raction when using hSAX, as compared with 69% for RP-LC. We also
nd that hSAX displays some bias towards preferential enrichment
f peptides from speciﬁc classes of proteins, particularly those with
ighly charged domains. HILIC provides a robust and reproducible
eparation method for high throughput proteomics. Like hSAX, it
elps to increase the depth of the proteome detected and is par-
icularly useful in enhancing the detection of a subset of proteins
hat may  otherwise be underrepresented, especially including pro-
eins with post translational modiﬁcations. This can be particularly
seful for biological experiments where it is important to detect
he roles of speciﬁc hydrophilic PTMs, such as phosphorylation and
roline hydroxylation, especially when it is not practical to include
TM-enrichment strategies in the experimental workﬂow.
It is likely that the performance of HILIC can be improved
ven further. For example, in this study, we observed undersam-
ling of peptides in the earlier HILIC fractions. By analyzing the
ydrophobic portion of the HILIC chromatogram, using standard
nline RP-LC–MS, no peptides were detected eluting for ∼40 min.
s the organic content of the mobile phase increased, peptides
f comparable hydrophobicity were then sprayed over a short
ime period, likely overloading the tandem MS (MS/MS) detec-
ion events and thus reducing the overall numbers of peptides
etected. A potential way to improve performance would thus be to
[
[
[ass Spectrometry 391 (2015) 105–114 113
modify the RP-LC–MS gradient according to the hydrophobicity of
the HILIC fractions, hence allowing earlier fractions to be analyzed
using a shallower gradient that starts with higher organic con-
tent, potentially leading to a greater number of peptide and protein
identiﬁcations.
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